BMS 707035 Uses, Dosage, Side Effects and more
BMS 707035 is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).
| Trade Name | BMS 707035 |
| Generic | HIV Integrase Inhibitor |
| HIV Integrase Inhibitor Other Names | BMS 707035 |
| Type | |
| Formula | C17H19FN4O5S |
| Weight | Average: 410.42 Monoisotopic: 410.106019065 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
